ABT
Stock Details
ABT is Abbott Laboratories's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 108.83$. Average daily volumn in 3 months 4.87M. Market cap 191.46B
Stock symbol : ABT. Exchange : NYSE. Currency : USD Lastest price : 109.81$. Total volume : 3.81M. Market state PRE Click reload if you want to check the lastest price on market!!!
Abbott Laboratories (ABT)
Last Price
109.81$Change
-0.14Volume
3.81M
| Previous Close | 109.95 |
| Open | 109.81 |
| Day Range | 109.62-110.67 |
| Bid | 109.02 x 800 |
| Ask | 109.84 x 800 |
| Volume | 3.81M |
| Average Volume | 4.87M |
| Market Cap | 191.46B |
| Beta | 0.67 |
| 52 Week Range | 93.25-130.94 |
| Trailing P/E | 28.08 |
| Foward P/E | 22.55 |
| Dividend (Yield %) | 1.86% |
| Ex-Dividend Date | 2023-01-12 |
Financial Details
Organization
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecologi... cal disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Market Cap:
191.46BRevenue:
43.65B
News about "Abbott Laboratories"
Abbott Labs under federal criminal investigation at Sturgis, Michigan baby formula factory
Source from : World Socialist Web Site - 16 hours ago
Anonymous sources have told corporate news media that the US Department of Justice is investigating Abbott Laboratories in connection with its baby formula manufacturing facility in Sturgis, Michigan, ...See details»
Abbott Laboratories: The 3 Issues That Will Define 2023 Performance
Source from : Seeking Alpha - 1 days ago
Three critical issues will dictate Abbott's stock performance in 2023. Read why, after 2023, ABT may morph back into a company investors know and love.See details»
Why Abbott Laboratories Stock Got Whacked on Wednesday
Source from : Nasdaq - 5 days ago
Wednesday morning, Abbott Laboratories (NYSE: ABT) beat on both the top and bottom lines in its freshly reported fourth quarter of 2022. This, however, was not good enough to send the veteran ...See details»
Abbott Laboratories stock falls Wednesday, underperforms market
Source from : MarketWatch - 6 days ago
Shares of Abbott Laboratories shed 1.36% to $111.00 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the ...See details»
Abbott Laboratories Full Year 2022 Earnings: EPS Beats Expectations
Source from : Yahoo - 4 days ago
The company's shares are down 1.6% from a week ago. Be aware that Abbott Laboratories is showing 1 warning sign in our investment analysis that you should know about ...See details»
Abbott Laboratories stock underperforms Tuesday when compared to competitors
Source from : MarketWatch - 7 days ago
Shares of Abbott Laboratories slipped 1.30% to $112.53 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the ...See details»
Abbott Labs confirms it is under scrutiny by U.S. in baby formula probe
Source from : UPI - 10 days ago
Jan. 21 (UPI) --Abbott Laboratories has confirmed it is under investigation by the Department of Justice in the wake of last year's closure of the company's infant formula manufacturing plant in ...See details»
Abbott Laboratories (ABT) Q4 2022 Earnings Call Transcript
Source from : Seeking Alpha - 6 days ago
Q4 2022 Earnings Conference Call January 25, 2023 9:00 AM ETCompany ParticipantsScott Leinenweber - Vice President, Investor RelationsRobert Ford ...See details»
Justice Department investigating Abbott Laboratories infant formula plant in Michigan
Source from : FOX13 Memphis - 9 days ago
Baby formula was reportedly recalled in Feb. 2022 after contamination was found at the Michigan plant that lead to a nationwide baby formula shortage.See details»
Abbott Laboratories confirms Justice Department probe following infant formula crisis
Source from : Medical Xpress - 8 days ago
Trouble continues for Abbott Laboratories, which shut down an infant formula plant last year amid reported illnesses. The U.S. Department of Justice is now investigating the company, though Abbott ...See details»
Abbott Laboratories Says It’s Cooperating With DOJ in Baby Formula Probe
Source from : Bloomberg L.P. - 10 days ago
Learn more Abbott Laboratories said it’s cooperating with the US Justice Department in a probe involving the contamination of baby formula at one of the company’s plants last year.See details»
What's in Store for Abbott Laboratories (ABT) in Q4 Earnings?
Source from : Yahoo - 14 days ago
Abbott Laboratories ABT is slated to report fourth-quarter 2022 results on Jan 25, before market open. In the last reported quarter, the company delivered an earnings surprise of 26.37%.See details»
Abbott Laboratories Not Yet in the Clear as We Approach Earnings
Source from : TheStreet.com - 7 days ago
Abbott Laboratories (ABT) is expected to report earnings on Wednesday before the market opens. Let's check the condition of the charts and indicators before shareholders get the company report card.See details»
Abbott Laboratories tops Q4 earnings
Source from : Yahoo Finance - 6 days ago
Yahoo Finance’s Anjalee Khemlani joins the Live show to break down fourth-quarter earnings for Abbott Laboratories. [AUDIO LOGO] BRAD SMITH: Let's also talk about Abbott-- Abbott Laboratories ...See details»